E for L Aim PCL
E for L Aim PCL provides healthcare equipment and related services in the advanced medical equipment and technology sector.
Business. E for L Aim PCL (EFORLM.BK) is a healthcare company engaged in the advanced medical equipment and technology industry, primarily operating through the sale of healthcare equipment. The firm is headquartered in Thailand and is listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
E for L Aim PCL (EFORLM.BK) is a healthcare company engaged in the advanced medical equipment and technology industry, primarily operating through the sale of healthcare equipment. The firm is headquartered in Thailand and is listed on the Stock Exchange of Thailand (SET). Specific details regarding its operating segments and geographic revenue mix are not available.
E for L Aim PCL has a debt-to-equity ratio of 0.89, indicating a moderate reliance on debt financing, and a current ratio of 1.45, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's free cash flow is negative at -13.73 million THB, and its operating cash flow is only 34.40 million THB, which may limit its ability to fund operations and growth without external financing.
The company's profitability is weak, with a return on equity of -4.44% and a return on assets of -1.71%, both significantly below the industry median for advanced medical equipment and technology firms. These metrics suggest the company is not generating returns that meet the cost of capital or industry benchmarks.
E for L Aim PCL's revenue is concentrated in a single economic region, with no disclosed segment or geographic diversification in the latest financials. This lack of diversification increases exposure to regional economic and regulatory risks, particularly in the healthcare equipment sector.
The company's revenue growth is not disclosed in the latest financials, but its operating income and net income are negative, indicating a contraction in profitability. The capital expenditure of -4.38 million THB suggests some investment in growth, but the negative net income and free cash flow indicate that this investment is not yet generating returns.
The risk assessment highlights a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could necessitate additional financing in the near term. However, the dilution risk is low, and no significant dilution sources are identified in the latest filings or transcripts.
No recent events, such as filings or transcripts, are disclosed in the available data to provide additional context on the company's strategic direction or operational performance.
- E for L Aim PCL has a moderate debt load and sufficient short-term liquidity but is generating negative free cash flow.
- The company's profitability metrics are significantly below industry medians, indicating poor returns on equity and assets.
- Revenue is concentrated in a single region, increasing exposure to local economic and regulatory risks.
- The company is investing in capital expenditures but is not yet generating positive returns on these investments.
- Liquidity risk is medium, and dilution risk is low, but the company's net cash position is negative.
Bull / Bear case
Generated · model-assistedNet income surged 126.3% year-over-year to 44.6 million THB, signaling a strong recovery in profitability.
Free cash flow increased 84.3% to 77.8 million THB, demonstrating improved operational cash generation capabilities.
Return on equity of -4.4% exceeds the cohort median of -4.7%, showing better capital efficiency than peers.
Long-term debt decreased to 300.7 million THB, reducing leverage and potential interest expense burdens.
The company carries high credit risk, suggesting significant potential for loan losses or default events.
Debt-to-equity ratio of 0.89 ranks in the bottom quartile, reflecting excessive leverage compared to peers.
Cash conversion of -1.54 ranks in the bottom quartile, indicating poor efficiency in generating cash from earnings.
In focus — financials by report
Revenue THB 399.5M; Operating income THB 46.8M.
- ▍Revenue THB 399.5M
- ▍Operating income THB 46.8M
- ▍Net margin 9.2%
Revenue THB 249.2M; Operating income -THB 12.1M.
- ▍Revenue THB 249.2M
- ▍Operating income -THB 12.1M
- ▍Net margin -8.2%
Revenue THB 1.49B, −31,1% YoY; Operating income −89,7% YoY.
- ▍Revenue THB 1.49B, −31,1% YoY
- ▍Operating income −89,7% YoY
- ▍Net income −93,5% YoY
- ▍Free cash flow −90,7% YoY
- ▍Net margin 3.6%
Revenue THB 2.17B; Operating income THB 826.8M.
- ▍Revenue THB 2.17B
- ▍Operating income THB 826.8M
- ▍Net margin 37.5%
Valuation FY
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- E for L Aim PCL Market data — financials · 2026-05-27